# Recurrent Infections in Allergic Pediatric Patients: An Immune System Problem? A Narrative Review

## TL;DR

This review explores how immune system issues in children with allergies make them more prone to recurring infections, especially respiratory ones.

## Contribution

The paper provides new insights into immune dysfunction in allergic children and its role in increasing infection susceptibility.

## Key findings

- Children with allergies show decreased interferon-gamma production, increasing vulnerability to viral and bacterial infections.
- Rhinovirus is the most common pathogen in asthma exacerbations among allergic children.
- Atopic children have higher rates of Mycoplasma pneumoniae infections compared to non-atopic children.

## Abstract

Background/Objectives: Recurring infections in children with allergies pose significant clinical challenges, with these conditions often exacerbating each other through complex immunological interactions. This narrative review examines the connection between recurring infections and allergic conditions in pediatric patients, focusing on how immune system dysfunction influences infection susceptibility in respiratory allergies. Methods: A comprehensive literature search across PubMed, Web of Science, and SciELO databases was conducted from January 2014 to May 2024. Studies involving children and adolescents up to 18 years old with diagnosed respiratory allergies were included, while reviews, opinion pieces, case reports, and studies not addressing immune–infection interactions were excluded. Results: Analysis reveals significant immune dysfunction in allergic children, affecting both innate and adaptive immunity components. Children with allergic rhinitis and asthma demonstrate decreased interferon-gamma production, increasing vulnerability to viral infections (particularly rhinovirus) and bacterial infections such as Mycoplasma pneumoniae. Rhinovirus represents the most common pathogen, present in 75% of asthma exacerbations. Atopic children exhibit markedly higher bacterial infection rates, with 27.1% showing Mycoplasma pneumoniae involvement versus 4.9% in non-atopic children. Conclusions: Recurring infections in allergic pediatric patients result from significant immune dysfunction involving altered cytokine production and immune cell function. These complex interactions highlight the need for targeted therapeutic approaches that enhance immune responses and reduce infection risks. Future research should focus on identifying specific biomarkers and immune mechanisms for developing more effective interventions.